HIV drugs offer ‘substantial’ Alzheimer’s protection, new research suggests

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer’s disease after discovering that patients taking the drugs are substantially less likely to develop the condition. The researchers have published their findings in Alzheimer’s & Dementia.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup